HLA tests in lung transplant

Not Applicable

Recruiting

• Conditions: advanced pulmonary disease; lung transplant, HLA, C1q, mismatch

• Registration Number: JPRN-jRCT1020210063
• Lead Sponsor: Okada Yoshinori

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-01-08
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Patients who undergo lung transplant between 2022 and 2024

Exclusion Criteria

Patients who refuse to provide the consent

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Short-term mortality after lung transplant (1-2 years post lung transplant)

Secondary Outcome Measures

Name	Time	Method
The fraction of the development of chronic lung allograft dysfunction (5-6 years post lung transplant)<br>Long-term mortality after lung transplant (5-6 years post lung transplant)